Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
44,652,587
-
Share change
-
+5,904,654
-
Total reported value
-
$2,002,347,126
-
Put/Call ratio
-
275%
-
Price per share
-
$44.84
-
Number of holders
-
180
-
Value change
-
+$252,906,375
-
Number of buys
-
105
-
Number of sells
-
84
Institutional Holders of KITE PHARMA INC - COM (KITE) as of Q4 2016
As of 31 Dec 2016,
KITE PHARMA INC - COM (KITE) was held by
180 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,652,587 shares.
The largest 10 holders included
Capital Research Global Investors, VANGUARD GROUP INC, JPMORGAN CHASE & CO, Wildcat Capital Management, LLC, BlackRock Fund Advisors, STATE STREET CORP, Capital World Investors, PRICE T ROWE ASSOCIATES INC /MD/, Capital International Investors, and MENORA MIVTACHIM HOLDINGS LTD..
This page lists
180
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.